Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R9CF
|
||||
| Former ID |
DNC008845
|
||||
| Drug Name |
4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromen-7-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H18O5
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)OCCCCOC2=C3C=CC(=O)OC3=CC4=C2C=CO4
|
||||
| InChI |
1S/C21H18O5/c22-20-9-8-16-19(26-20)14-18-17(10-13-24-18)21(16)25-12-5-4-11-23-15-6-2-1-3-7-15/h1-3,6-10,13-14H,4-5,11-12H2
|
||||
| InChIKey |
KINMYBBFQRSVLL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Potassium voltage-gated channel subfamily A member 3 | Target Info | Inhibitor | [1] | |
| Calcium-activated potassium channel | Target Info | Inhibitor | [2] | ||
| Potassium voltage-gated channel subfamily A member 5 | Target Info | Inhibitor | [1] | ||
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| Reactome | Voltage gated Potassium channelsR-HSA-1296072:Voltage gated Potassium channels | ||||
| WikiPathways | Potassium Channels | ||||
| BDNF signaling pathwayWP2669:Potassium Channels | |||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2010 Dec 1;20(23):6989-92. Epub 2010 Oct 23.Substituted N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 ion channel blockers. Part 2. | ||||
| REF 2 | Bioorg Med Chem Lett. 2009 Apr 15;19(8):2299-304. Epub 2009 Feb 25.Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.